Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver Disease
Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
To explore the effectiveness and biobehavioural basis of baclofen in improving treatment
outcomes for alcohol dependence in people with or without alcoholic cirrhosis in a
double-blind randomised placebo-controlled trial.
Phase:
Phase 3
Details
Lead Sponsor:
South West Sydney Local Health District
Collaborators:
National Health and Medical Research Council, Australia University of Sydney